5RHEE C K, LEE S H, YOON H K, et al. Effect of nilotinib on bleomycin-induced acute lung injury and pulmonaryfibrosis in mice [ J ]. Respiration, 2011,82 ( 3 ) :273-287.
6D'ALESSANDRO-GABAZZA C N, KOBAYASHI T, BO- VEDA D, et al. Development and preclinical efficacy of novel transforming growth factor-β1 siRNAs for pulmonary fibrosis [ J ]. Am J Respir Cell Mol Biol, 2011, [ Epub ahead of print].
6Nathan SD,Shlobin OA,Weir N,et al. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium [ J ]. Chest, 2011,140(1) : 221-229.
7Kim .IY, Choeng HC, Ahn C,et al. Early and late changes of MMP-2 and MMP-9 in bleomyein-indueed pulmonary fibrosis [ J ]. Yonsei Ned J ,2009,50 ( 1 ) :68-77.
9Hemnes AR, Zaiman A, Champion HC. PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rhn kinase activation [ J]. Am J Physiol Lung Cell Mol Physio1,2008,294 (1) :L24-135.
10Song JS, Kang CM, Rhee CK, et al. Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis [ J]. Exp Lung Res,2009,35 (10) :817-829.
